Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Fritzberg

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
AJR. American Journal of Roentgenology|July 1, 1982
Cholescintigraphy in extrahepatic biliary obstructionW C Klingensmith, C C Kuni, A R Fritzberg
Gastrointestinal Radiology|January 1, 1984
Evaluation of intrahepatic cholestasis with radionuclide hepatobiliary imagingC C Kuni, W C Klingensmith, A R Fritzberg
AJR. American Journal of Roentgenology|November 1, 1978
Bile leak into a hepatic abscess in a liver transplant: demonstration with 99mTc-diethyl-iminodiacetic acidW C Klingensmith, L J Koep, A R Fritzberg
International Journal of Nuclear Medicine and Biology|January 1, 1978
99mTc-glutathione: role of reducing agent on renal retentionA R Fritzberg, D M Lyster, D H Dolphin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1976
99mTc-bioquin-7CA, a potential new hepatobiliary scanning agentA R Fritzberg, D M Lyster, D H Dolphin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1979
Comparison of Tc-99m diethyl-iminodiacetic acid and I-131 rose bengal for hepatobiliary studies in liver-transplant patients: Concise communicationW C Klingensmith, A R Fritzberg, L J Koep
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1977
Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticalsA R Fritzberg, D M Lyster, D H Dolphin
Journal of Medicinal Chemistry|October 1, 1986
Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticalsS Kasina, A R Fritzberg, D L Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1986
Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacementA R Fritzberg, S Kasina, D Eshima, et al.
Nuclear Medicine and Biology|August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseasesM Chianelli, A Signore, A R Fritzberg, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
AJR. American Journal of Roentgenology|July 1, 1982
Cholescintigraphy in extrahepatic biliary obstructionW C Klingensmith, C C Kuni, A R Fritzberg
Gastrointestinal Radiology|January 1, 1984
Evaluation of intrahepatic cholestasis with radionuclide hepatobiliary imagingC C Kuni, W C Klingensmith, A R Fritzberg
AJR. American Journal of Roentgenology|November 1, 1978
Bile leak into a hepatic abscess in a liver transplant: demonstration with 99mTc-diethyl-iminodiacetic acidW C Klingensmith, L J Koep, A R Fritzberg
International Journal of Nuclear Medicine and Biology|January 1, 1978
99mTc-glutathione: role of reducing agent on renal retentionA R Fritzberg, D M Lyster, D H Dolphin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1976
99mTc-bioquin-7CA, a potential new hepatobiliary scanning agentA R Fritzberg, D M Lyster, D H Dolphin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1979
Comparison of Tc-99m diethyl-iminodiacetic acid and I-131 rose bengal for hepatobiliary studies in liver-transplant patients: Concise communicationW C Klingensmith, A R Fritzberg, L J Koep
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1977
Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticalsA R Fritzberg, D M Lyster, D H Dolphin
Journal of Medicinal Chemistry|October 1, 1986
Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticalsS Kasina, A R Fritzberg, D L Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1986
Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacementA R Fritzberg, S Kasina, D Eshima, et al.
Nuclear Medicine and Biology|August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseasesM Chianelli, A Signore, A R Fritzberg, et al.
Pageof 6